Bayer

Last updated January 31, 2026

432

Innovation Areas

13,147

Inventors

104

Collaborations

N-methylglucamide viral inactivation chemistry: BayerRecent Research Landscape

Viral contamination in cell-based manufacturing risks catastrophic batch loss and patient safety. These innovations utilize specific detergent derivatives and microfluidic integration to neutralize pathogens without damaging sensitive cellular products.

What technical problems is Bayer addressing in N-methylglucamide viral inactivation chemistry?

Pathogen contamination in bioprocessing

(6)evidences

Uncontrolled viral presence and fluctuating moisture levels compromise biopharmaceutical purity and safety. Precise monitoring and inactivation prevent batch failure and ensure regulatory compliance.

Bioreactor cell aggregate accumulation

(4)evidences

Manual handling during dissociation and culture leads to high variability and contamination risks. Automating these steps ensures reproducible biological yields and process scalability.